BeStock  
Markets › Compare › OMER vs JBIO

OMER vs JBIO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
OMER · Omeros$13.21 ▼ 5.71%
JBIO · Jade Biosciences$15.31 ▲ 1.66%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

81118155192229Nov 24, '25May 26, '26Nov 20, '26
  • OMER +35.3%
  • JBIO +26.0%

Head to head

MetricOMERJBIO
Price$13.21$15.31
Change today▼ 5.71%▲ 1.66%
Market cap$983.66M$1.06B
Return, 3 months-31.6%-28.2%
Return, year to date-23.1%-0.8%
Return, 1 year+48.9%+27.6%
P/E (TTM)8.5–
P/B-10.92.3
P/E percentile vs own 5y90th11th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)+152.0%-39.2%
Gross margin97.2%–
Operating margin-189.5%–
Net margin324.9%–
Return on equity–-51.4%
Analyst target vs. price+108.2%+244.0%
Analyst buy share100%100%
RSI (14)3151
30-day volatility85.2%53.3%
Max drawdown, 1 year-49.5%-50.1%
Trend readStrong downtrendLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • JBIO is the largest of the group by market value.
  • OMER has returned the most over the past year.
  • JBIO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top